Literature DB >> 29572283

Cerebellar volume as an imaging marker of development in infants with tuberous sclerosis complex.

Siddharth Srivastava1, Anna K Prohl1, Benoit Scherrer1, Kush Kapur1, Darcy A Krueger1, Simon K Warfield1, Mustafa Sahin2.   

Abstract

OBJECTIVE: In this cohort analysis, we studied 1-year-old infants with tuberous sclerosis complex (TSC), correlating volumes of cerebellar structures with neurodevelopmental measures.
METHODS: We analyzed data from a prospective biomarker study in infants with TSC (ClinicalTrials.gov NCT01780441). We included participants aged 12 months with an identified mutation of TSC1 or TSC2. Using MRI segmentation performed with the PSTAPLE algorithm, we measured relative volumes (structure volume divided by intracranial contents volume) of the following structures: right/left cerebellar white matter, right/left cerebellar exterior, vermal lobules I-V, vermal lobules VI-VII, and vermal lobules VIII-X. We correlated relative volumes to Mullen Scales of Early Learning (MSEL) scores.
RESULTS: There were 70 participants (mean age 1.03 [0.11] years): n = 11 had a TSC1 mutation; n = 59 had a TSC2 mutation. For patients with TSC2 mutation, for every percentage increase in total cerebellar volume, there was an approximate 10-point increase in MSEL composite score (β = 10.47 [95% confidence interval 5.67, 15.27], p < 0.001). For patients with TSC1 mutation, the relationship between cerebellar volume and MSEL composite score was not statistically significant (β = -10.88 [95% confidence interval -22.16, 0.41], p = 0.06). For patients with TSC2 mutation, there were positive slopes when regressing expressive language and visual reception skills with volumes of nearly all cerebellar structures (p ≤ 0.29); there were also positive slopes when regressing receptive language skills, gross motor skills, and fine motor skills with volumes of cerebellar right/left exterior (p ≤ 0.014).
CONCLUSIONS: Cerebellar volume loss-perhaps reflecting Purkinje cell degeneration-may predict neurodevelopmental severity in patients with TSC2 mutations.
© 2018 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29572283      PMCID: PMC5921037          DOI: 10.1212/WNL.0000000000005352

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

1.  mTORC1 and mTORC2 have largely distinct functions in Purkinje cells.

Authors:  Nico Angliker; Michael Burri; Mariana Zaichuk; Jean-Marc Fritschy; Markus A Rüegg
Journal:  Eur J Neurosci       Date:  2015-09-18       Impact factor: 3.386

2.  Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex.

Authors:  C Joinson; F J O'Callaghan; J P Osborne; C Martyn; T Harris; P F Bolton
Journal:  Psychol Med       Date:  2003-02       Impact factor: 7.723

3.  Manifestations of Tuberous Sclerosis Complex: The Experience of a Provincial Clinic.

Authors:  Colin Wilbur; Chinnuwat Sanguansermsri; Hedi Chable; Mihaela Anghelina; Sharon Peinhof; Kelly Anderson; Paul Steinbok; Ash Singhal; Anita Datta; Mary B Connolly
Journal:  Can J Neurol Sci       Date:  2017-01       Impact factor: 2.104

4.  Diffusion features of white matter in tuberous sclerosis with tractography.

Authors:  Michelle L Krishnan; Olivier Commowick; Shafali S Jeste; Neil Weisenfeld; Arne Hans; Matthew C Gregas; Mustafa Sahin; Simon K Warfield
Journal:  Pediatr Neurol       Date:  2010-02       Impact factor: 3.372

5.  Simultaneous truth and performance level estimation through fusion of probabilistic segmentations.

Authors:  Alireza Akhondi-Asl; Simon K Warfield
Journal:  IEEE Trans Med Imaging       Date:  2013-06-04       Impact factor: 10.048

6.  Regional cerebellar volumes predict functional outcome in children with cerebellar malformations.

Authors:  Marie-Eve Bolduc; Adre J du Plessis; Nancy Sullivan; Nicolas Guizard; Xun Zhang; Richard L Robertson; Catherine Limperopoulos
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

7.  Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States.

Authors:  Kit Sing Au; Aimee T Williams; E Steve Roach; Lori Batchelor; Steven P Sparagana; Mauricio R Delgado; James W Wheless; James E Baumgartner; Benjamin B Roa; Carolyn M Wilson; Teresa K Smith-Knuppel; Min-Yuen C Cheung; Vicky H Whittemore; Terri M King; Hope Northrup
Journal:  Genet Med       Date:  2007-02       Impact factor: 8.822

Review 8.  The growing role of mTOR in neuronal development and plasticity.

Authors:  Jacek Jaworski; Morgan Sheng
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

Review 9.  The Role of the Pediatric Cerebellum in Motor Functions, Cognition, and Behavior: A Clinical Perspective.

Authors:  Michael S Salman; Peter Tsai
Journal:  Neuroimaging Clin N Am       Date:  2016-08       Impact factor: 2.264

10.  The natural history of epilepsy in tuberous sclerosis complex.

Authors:  Catherine J Chu-Shore; Philippe Major; Susana Camposano; David Muzykewicz; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2009-12-22       Impact factor: 5.864

View more
  4 in total

1.  Impacting development in infants with tuberous sclerosis complex: Multidisciplinary research collaboration.

Authors:  Marian E Williams; Deborah A Pearson; Jamie K Capal; Anna W Byars; Donna S Murray; Robin Kissinger; Sarah E O'Kelley; Ellen Hanson; Nicole M Bing; Bridget Kent; Joyce Y Wu; Hope Northrup; E Martina Bebin; Mustafa Sahin; Darcy Krueger
Journal:  Am Psychol       Date:  2019-04

2.  Resting-State fMRI Networks in Children with Tuberous Sclerosis Complex.

Authors:  Banu Ahtam; Mathieu Dehaes; Danielle D Sliva; Jurriaan M Peters; Darcy A Krueger; Elizabeth Martina Bebin; Hope Northrup; Joyce Y Wu; Simon K Warfield; Mustafa Sahin; Patricia Ellen Grant
Journal:  J Neuroimaging       Date:  2019-07-14       Impact factor: 2.486

3.  Tractography of the Cerebellar Peduncles in Second- and Third-Trimester Fetuses.

Authors:  F Machado-Rivas; O Afacan; S Khan; B Marami; C K Rollins; C Ortinau; C Velasco-Annis; S K Warfield; A Gholipour; C Jaimes
Journal:  AJNR Am J Neuroradiol       Date:  2021-01       Impact factor: 3.825

4.  Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span.

Authors:  Jana E Jones; Miya R Asato; Mesha-Gay Brown; Julia L Doss; Elizabeth A Felton; Jennifer A Kearney; Delia Talos; Penny A Dacks; Vicky Whittemore; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2020-01-23       Impact factor: 7.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.